DUPA
CAS No. 302941-52-2
DUPA( (2S,2'S)-2,2'-Carbonylbis(Azanediyl)Dipentanedioic Acid | N,N''-Carbonylbis[L-glutamic acid] )
Catalog No. M27072 CAS No. 302941-52-2
DUPA is used as the targeting moiety to actively deliver DTX for treatment of Prostate-Specific Membrane Antigen (PSMA) expressing prostate cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 33 | Get Quote |
|
| 5MG | 53 | Get Quote |
|
| 10MG | 87 | Get Quote |
|
| 25MG | 158 | Get Quote |
|
| 50MG | 267 | Get Quote |
|
| 100MG | 410 | Get Quote |
|
| 200MG | 591 | Get Quote |
|
| 500MG | 888 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDUPA
-
NoteResearch use only, not for human use.
-
Brief DescriptionDUPA is used as the targeting moiety to actively deliver DTX for treatment of Prostate-Specific Membrane Antigen (PSMA) expressing prostate cancer.
-
DescriptionDUPA is used as the targeting moiety to actively deliver DTX for treatment of Prostate-Specific Membrane Antigen (PSMA) expressing prostate cancer.(In Vitro):After binding to a DUPA-drug conjugate, PSMA internalizes, unloads the conjugate, and returns to the surface.(In Vivo):As determined by loss of body weight and death of treated mice,DUPA-indenoisoquinoline conjugate induces a complete cessation of tumor growth with no toxicity.
-
In VitroDUPA is used as the targeting moiety to actively deliver Docetaxel (DTX) for treatment of prostate-specific membrane antigen (PSMA) expressing prostate cancer. The DUPA-indenoisoquinoline conjugate exhibits an IC50 in the low nanomolar range in 22RV1 cell cultures.
-
In VivoThe DUPA-indenoisoquinoline conjugate induces a complete cessation of tumor growth with no toxicity, as determined by loss of body weight and death of treated mice.
-
Synonyms(2S,2'S)-2,2'-Carbonylbis(Azanediyl)Dipentanedioic Acid | N,N''-Carbonylbis[L-glutamic acid]
-
PathwayOthers
-
TargetOther Targets
-
Recptor20S proteasome
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number302941-52-2
-
Formula Weight320.254
-
Molecular FormulaC11H16N2O9
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 300 mg/mL (936.77 mM)
-
SMILES[H][C@@](CCC(O)=O)(NC(=O)N[C@@]([H])(CCC(O)=O)C(O)=O)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Encouse B Golden, et al. Green Tea Polyphenols Block the Anticancer Effects of Bortezomib and Other Boronic Acid-Based Proteasome Inhibitors. Blood. 2009 Jun 4;113(23):5927-37.
molnova catalog
related products
-
X-press Tag Peptide
X-press Tag is an N-terminal leader peptide; this N-terminal peptide contains a polyhistidine sequence, the Xpress epitope (part of bacteriophage T7 gene 10 protein) and an enterokinase cleavage site. Anti-Xpress antibodies recognize the Xpress epitope sequence found in this leader peptide.
-
Isoangustone A
Isoangustone A has antitumor activity, it can induce G1 cycle arrest in DU145 human prostate and 4T1 murine mammary cancer cells, it inhibits cell proliferation by targeting PI3K, MKK4, and MKK7 in human melanoma.
-
AUDA
AUDA is an inhibitor of sEH(IC50 values of 18 and 69 nM for the mouse and human enzymes respectively).
Cart
sales@molnova.com